- Medical School - University of Texas Health Science Center at San Antonio (2006-2014)
- Internship - John Peter Smith Hospital (2014-2015), Transitional Year
- Residency - UT Southwestern Medical Center (2015-2019), Radiation Oncology
Dat Vo, M.D., Ph.D.
- Radiation Oncology
- Head & Neck Cancers
- Laryngeal Cancer
Dr. Vo received his B.S. from the University of Texas at Austin, and earned both his M.D. and Ph.D. at the University of Texas School of Medicine in San Antonio. He performed his internship at John Peter Smith Hospital, and his residency at UT Southwestern, where he served as Chief Resident.
Meet Dr. Vo
Dat Vo, M.D., Ph.D., a native of Fort Worth, joined the UT Southwestern faculty after completing his residency in radiation oncology at UT Southwestern.
His interests include post-transcriptional gene regulation, nucleic acid-based diagnostics and therapeutics, and clinical radiation oncology with a particular interest in head and neck cancer.
“One of the most gratifying aspects of being a radiation oncologist is the relationships that I can cultivate with my patients," says Dr. Vo.
"Radiation therapy is a powerful treatment for cancer, but it is equally powerful to be there alongside my patients—helping to guide them through this tough time in their lives. Moreover, I have the opportunity to work and collaborate with many professionals, including nurses and dietitians, to give our patients the care and expertise they need. At UT Southwestern, we are fortunate to have great clinicians that are dedicated to head and neck cancer, offering exceptional cancer care and clinical trials investigating novel strategies and modalities for fighting cancer. Lastly, as a native of Fort Worth, it has been a special honor and privilege to come home and care for patients in Dallas and Fort Worth.”
- American Association of Cancer Research
- American Brachytherapy Society
- American College of Radiation Oncology
- American Society for Clinical Oncology
- American Society for Radiation Oncology
- Radiological Society of North America
- RNA Society
- ASTRO Annual Meeting Resident Poster Viewing Recognition Award 2018
- American College of Radiation Oncology Resident Seed Grant 2017
- Barbara Bowman Student of the Year Award, Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio 2012
- Rennels Memorial Award for Excellence in Graduate Studies, Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio 2011
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT, Karanam NK, Ding L, Saha D, Yordy JS, Giri U, Heymach JV, Story MD, Neoplasia (New York, N.Y.) 2019 Jul 21 9 849-862
Deep inspiration breathhold for left-sided breast cancer patients with unfavorable cardiac anatomy requiring internal mammary nodal irradiation.
Mohamad O, Shiao J, Zhao B, Roach K, Ramirez E, Vo DT, Thomas K, Gu X, Spangler A, Albuquerque K, Rahimi A, Practical radiation oncology 2017 Nov - Dec 7 6 e361-e367
Novel Use of an Image-Guided Stereotactic Approach in Trauma for Localization of Transcranial Bullet.
Vo DT, Cravens GF, Germann RE, Cureus 2017 Jul 9 7 e1501
Streptococcus pneumoniae meningitis complicated by an intramedullary abscess: a case report and review of the literature.
Vo DT, Cravens GF, Germann RE, Journal of medical case reports 2016 Oct 10 1 290
Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.
de Araujo PR, Gorthi A, da Silva AE, Tonapi SS, Vo DT, Burns SC, Qiao M, Uren PJ, Yuan ZM, Bishop AJ, Penalva LO, The American journal of pathology 2016 09 186 9 2271-8
Isolated hemangioblastoma of the cervical spinal cord: A case report and literature review.
Vo DT, Cravens GF, Germann RE, International journal of surgery case reports 2016 26 7-11
RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.
Uren PJ, Vo DT, de Araujo PR, Pötschke R, Burns SC, Bahrami-Samani E, Qiao M, de Sousa Abreu R, Nakaya HI, Correa BR, Kühnöl C, Ule J, Martindale JL, Abdelmohsen K, Gorospe M, Smith AD, Penalva LO, Molecular and cellular biology 2015 Sep 35 17 2965-78
RNA binding protein HuR regulates the expression of ABCA1.
Ramírez CM, Lin CS, Abdelmohsen K, Goedeke L, Yoon JH, Madrigal-Matute J, Martin-Ventura JL, Vo DT, Uren PJ, Penalva LO, Gorospe M, Fernández-Hernando C, Journal of lipid research 2014 06 55 6 1066-76
Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.
Tamim S, Vo DT, Uren PJ, Qiao M, Bindewald E, Kasprzak WK, Shapiro BA, Nakaya HI, Burns SC, Araujo PR, Nakano I, Radek AJ, Kuersten S, Smith AD, Penalva LO, PloS one 2014 9 1 e85591
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT, Subramaniam D, Remke M, Burton TL, Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U, Korshunov A, Dubuc AM, Northcott PA, Smith AD, Pfister SM, Taylor MD, Janga SC, Anant S, Vogel C, Penalva LO, The American journal of pathology 2012 Nov 181 5 1762-72
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
Vo DT, Abdelmohsen K, Martindale JL, Qiao M, Tominaga K, Burton TL, Gelfond JA, Brenner AJ, Patel V, Trageser D, Scheffler B, Gorospe M, Penalva LO, Molecular cancer research : MCR 2012 Jan 10 1 143-55
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO, RNA biology 2011 Sep-Oct 8 5 817-28
Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.
de Sousa Abreu R, Sanchez-Diaz PC, Vogel C, Burns SC, Ko D, Burton TL, Vo DT, Chennasamudaram S, Le SY, Shapiro BA, Penalva LO, The Journal of biological chemistry 2009 May 284 18 12125-35
- miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
- Post-transcriptional gene regulation
- Nucleic acid-based diagnostics
- Clinical radiation oncology with a particular interest in head and neck cancer
- Head & Neck Cancers
- Laryngeal Cancer
- Airway Cancer